The Parker Institute for Cancer Immunotherapy (PICI) recently announced its 2021 class of early career researcher award recipients, a group […]
The clinical research as a care option has come a long way in the large, massive, primarily rural State of […]
The University of Kansas Cancer Center has developed a new mobile app to match anyone looking for specific cancer trials with […]
One of the largest gifts, even in support of cancer research, $250 million thanks to Mr. and Mrs. William H. […]
We sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started […]
Danish biotech venture Genmab in partnership with American multinational pharmaceutical company AbbVie recently launched a Phase 3 clinical trial to […]
An interview with Dr. Gerald Maguire about the Phase 2 Speak Freely Study, which is a multicenter, randomized, double-blind, placebo-controlled, […]
The U.S. Food and Drug Administration granted approval of a drug that is the first immunotherapy treatment indicated for patients […]
We discuss “Smart” Natural Killer Cells for Cancer Treatment, Sonny Hsiao of Acepodia. A clinical trial targeting HER2-expressing solid […]
An Erasmus MC biotech venture spin-off was announced recently in Rotterdam, Netherlands. Pan Cancer T B.V., founded by Prof. Dr. […]
